Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NDT Pharmaceuticals's share price for the quarter that ended in Jun. 2008 was $1010. NDT Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Jun. 2008 was 0.04 Mil. Therefore, NDT Pharmaceuticals's market cap for the quarter that ended in Jun. 2008 was $42.77 Mil.
NDT Pharmaceuticals's quarterly market cap
increased
from Dec. 2007 ($0.00 Mil) to Mar. 2008 ($50.82 Mil) but then
declined
from Mar. 2008 ($50.82 Mil) to Jun. 2008 ($42.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NDT Pharmaceuticals's Enterprise Value for Today is $24.00 Mil.
NDT Pharmaceuticals Market Cap Historical Data
The historical data trend for NDT Pharmaceuticals's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NDT Pharmaceuticals's Market Cap
For the Biotechnology subindustry, NDT Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NDT Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where NDT Pharmaceuticals's Market Cap falls into.
NDT Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
NDT Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2007 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NDT Pharmaceuticals (OTCPK:NDTP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
NDT Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of NDT Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NDTP has been successfully added to your 